Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
Best healthcare stocks to buy in 2021
Here our experts choose their favourite healthcare stocks for you to invest in. From the old hand businesses that have been around for many years to the cool new kids on the block, this list contains the best of them all.
What are the top healthcare stocks to buy?
The table below displays our healthcare stock picks. You can find their most up to date market price by following the links, or keep reading to learn more about why each one was chosen in more detail.
|#||Stock ticker||Company name|
|2||JNJ||Johnson & Johnson|
|4||CLOV||Clover Health Investments|
1. Veeva Systems (NYSE: VEEV)
Veeva is an American company that specialises in software for the healthcare industry. It helps companies track clinical trials, manage customer relationships, and generally be more efficient and provide a better service to their patients.
There are few other businesses that offer anything similar. With that first-mover advantage, Veeva has become a popular stock over the last couple of years. Its share price grew 150% in the year following the March 2020 coronavirus crash as it kept adding more big name clients to its roster of subscribers.
Veeva is top of this list because of both its unique offering and that subscription-based revenue stream. Not only does it keep adding new clients, it keeps the existing ones and regularly upsells them onto a bigger package. It has high profit margins and already counts the likes of Pfizer and AstraZeneca as clients, which bodes extremely well for the future.
2. Johnson & Johnson (NYSE: JNJ)
On the other end of the scale, Johnson & Johnson is one of the grand old names of American healthcare. Founded in 1886, it’s one of the biggest companies in the US and one of the most valuable companies in the world.
J&J suits an investor who prefers long term reliability over a more risky growth profile. It has paid a dividend every year for half a century and is well established as the leader in American healthcare. It makes money from selling medicine, developing new drugs, and by designing medical devices.
That has helped it steadily increase its share price over many decades and there’s no reason to expect any faltering in performance. Even during difficult economic times, people still get sick and Johnson & Johnson has proven its ability to keep increasing its dividend regardless of the global situation.
3. Intuitive Surgical (NASDAQ: ISRG)
Intuitive Surgical is a US company that has helped to pioneer robotic surgery. It creates robotics systems known as the Da Vinci surgical system that automatically performs surgical procedures.
It has been one of the most popular stocks on the market since the coronavirus crash in March 2020. Technology stocks did well throughout the pandemic and as more people started to have surgery again as the worst of the crisis passed on, Intuitive’s stock took off, doubling in value over the course of the following year.
Along with the success of its technology so far, a big reason for its place on this list is the number of procedures that are possible with its Da Vinci system. There are more than six million surgeries every year that its robotics could be used for, which could be a major source of revenue in the not too distant future.
4. Clover Health Investments (NASDAQ: CLOV)
Clover Health is another US-based healthcare technology company. It uses data analysis to help patients and physicians develop personalised healthcare plans. It’s mainly targeted at older people and hopes to improve decision making and treatments.
Clover has only been a public company since the start of 2021 so there is limited stock performance to go on so far. What there has been is volatility, not least because the company is one of the stocks that came to the attention of retail traders on Reddit, leading to a 150% rise in value in the summer.
It’s on this list because of the potential of using technology to create a more efficient healthcare system. Insurance is also a big money business in the United States and Clover has more than 100,000 patients under contract already.
5. Mind Medicine (NASDAQ: MNMD)
As its name suggests, Mind Medicine is a company that focuses on mental health. Based in the United States, it is developing psychedelic and therapeutic treatments to address issues like anxiety and depression.
Mind Meidicne is another young company in stock market terms, having only been available to trade since 2020. It has yet to really take off, not least because its treatments are controversial – psychedelic treatments are not even legal in many countries – and it has lost a lot of money so far.
However, that’s quite normal for a modern biotech company. It’s more risky than the other companies on this list but it has a lot of potential if the treatments were to prove to work. The flag bearer for this form of healthcare company is Moderna, which returned losses for many years until its revolutionary new technology started producing results.
Where to buy the best healthcare shares
These platforms below are the best places to get stocks now. You can head to the website using the links in the table or read our reviews to learn more about each one.
What is a healthcare stock?
Any company that’s involved in developing, buying, or selling medical products. The healthcare sector is extremely large and tends to be a good industry to own stocks in if you want to own companies that can perform even when the economic situation is tough.
Are healthcare shares a good investment?
The big names in healthcare have traditionally been good stocks to own. That means the likes of Johnson & Johnson, who usually pay handsome dividends and can balance your portfolio because they are less affected by the peaks and troughs of the economy.
However, these companies spend a lot of money on research and development. It’s a constant battle to stay ahead and to discover new treatments, which means that the newer breed of healthcare business that focuses exclusively on that tends to be more risky. They are more like tech stocks, which are high risk, high reward investments.
Ultimately, which type of healthcare stock you prefer is down to you. It might depend on the other companies you own, or you might want to take a bet on a particular treatment hitting it big. Either way, you should follow the latest news in order to stay ahead, as competitor treatments or new science can have a major impact on the stock price of everyone in the industry.
Latest healthcare news
Is it time to buy Covid stocks? Moderna CEO thinks pandemic could end in a year
Here’s why TransCode Therapeutics stock is up about 65% on Thursday
Should you buy SAVA stock in Q4 2021 amid positive Simufilam trial data?
Here’s why BeyondSpring shares are up more than 25% on Monday
Pfizer completes its next milestone in the battle against the pandemic
Philip Morris extends deadline to seal a deal for UK’s Vectura amidst concerns
Invezz is a place where people can find reliable, unbiased information about finance, trading, and investing – but we do not offer financial advice and users should always carry out their own research. The assets covered on this website, including stocks, cryptocurrencies, and commodities can be highly volatile and new investors often lose money. Success in the financial markets is not guaranteed, and users should never invest more than they can afford to lose. You should consider your own personal circumstances and take the time to explore all your options before making any investment. Read our risk disclaimer >